CRISPR-on-Chip for Point-of-Care Diagnostics
Karolinska University Hospital · Koç University · +5 more institutions
Abstract
CRISPR-based diagnostic platforms have gained significant momentum in recent years, enabling highly sensitive and specific detection of pathogens and diseases. Due to their practical benefits, these platforms have become widely adopted in point-of-care (PoC) applications. CRISPR-on-chip technology integrates CRISPR-Cas platforms with diverse microfluidic systems, allowing scalability and portable, real-time, and precise biomolecule detection. This approach enhances diagnostic accuracy, reduces processing times, and minimizes the need for complex laboratory infrastructures, unlike in conventional diagnostics. Using CRISPR-Cas enzymes in microfluidic systems, CRISPR-on-chip platforms offer key advantages such as…
Citation impact
- FWCI
- 72.37
- Percentile
- 100%
- References
- 134
Authors
4- NANazente Atçeken
Karolinska University Hospital, Koç University, Karolinska Institutet, Austrian Society of Dermatology and Venereology, Indiana University School of Medicine
- AKAlptekin Kahya
Koç University
- DYDefne Yigci
Koç University, Indiana University School of Medicine
- STSavaş TaşoğluCorresponding
Koç University, Arçelik (Turkey), Artificial Intelligence in Medicine (Canada)
Topics & keywords
- Microfluidics
- Multiplex
- Scalability
- Key (lock)
- Molecular diagnostics
- Industry, innovation and infrastructure